- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04355819
Patient Centered Outcomes Study
June 21, 2023 updated by: Julie Holihan, The University of Texas Health Science Center, Houston
Patient Centered Outcomes Among Patients With and Without Ventral Hernia
Several questions exist when looking at ventral hernias:
- what is the baseline quality of life and abdominal wall function among patients with or without a ventral hernia?
- what is the clinical significance of a ventral hernia seen on radiography but not on clinical examination (e.g. occult hernia)?
- what is the natural history of quality of life of patients with and without a ventral hernia?
- what is the impact of disclosure of presence or absence of a ventral hernia on quality of life?
Answering these questions can provide valuable information on the impact of surgery with or without subsequent ventral hernia on a patient's abdominal wall function and quality of life.
Study Overview
Study Type
Interventional
Enrollment (Actual)
500
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Texas
-
Houston, Texas, United States, 77026
- Lyndon B. Johnson General Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Adults age 18 years or older
- Patients at LBJ Hospital
- Patients who received a CT of the abdomen
Exclusion Criteria:
- Children (under age 18 years old)
- Any patient in any vulnerable population (e.g pregnant women, prisoners, etc.)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Disclosure before
Patients will be told that a hernia was found on CT before the follow-up survey is administered.
|
When patients are told that a hernia was present on the CT scan
|
|
Experimental: Disclosure after
Patients will be told that a hernia was found on CT after the follow-up survey was administered.
|
When patients are told that a hernia was present on the CT scan
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient Centered Outcomes (PCO)
Time Frame: Consent to 1 year follow-up
|
Difference in PCO from initial survey to follow-up survey
|
Consent to 1 year follow-up
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Julie Holihan, MD, The University of Texas Health Science Center, Houston
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 29, 2016
Primary Completion (Actual)
October 3, 2018
Study Completion (Actual)
October 3, 2018
Study Registration Dates
First Submitted
April 17, 2020
First Submitted That Met QC Criteria
April 17, 2020
First Posted (Actual)
April 21, 2020
Study Record Updates
Last Update Posted (Actual)
June 23, 2023
Last Update Submitted That Met QC Criteria
June 21, 2023
Last Verified
June 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HSC-MS-16-0698
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hernia, Ventral
-
Varazdin General HospitalCompletedIncisional Ventral Hernia | Recurrent Ventral HerniaCroatia
-
Anne Arundel Health System Research InstituteMedtronic - MITGCompletedGrade I Ventral Hernia | Grade II Ventral HerniaUnited States
-
Sofregen Medical, Inc.TerminatedVentral Hernia RepairUnited States
-
University Hospital, Strasbourg, FranceRecruitingVentral Hernia RepairFrance
-
Makassed General HospitalSuspended
-
GSVM Medical CollegeCompleted
-
Zaza DemetrashviliRecruitingLarge Midline Ventral HerniaGeorgia
-
Hvidovre University HospitalUniversity of CopenhagenCompleted
-
Hvidovre University HospitalCopenhagen University Hospital at HerlevCompleted
-
Distalmotion SAConfinisCompletedVentral Hernia RepairSwitzerland, Austria, France, Germany
Clinical Trials on Disclosure timing
-
University of UtahCompletedAge-Related Macular Degeneration | Choroidal Neovascularization | Genetic CounselingUnited States
-
Morehead State UniversityTerminated
-
University of MichiganNational Institute on Aging (NIA)Active, not recruitingAlzheimer Disease | Mild Cognitive Impairment | Amnestic Mild Cognitive DisorderUnited States
-
The Cleveland ClinicCompletedConflicts of Interest
-
Brigham and Women's HospitalNational Human Genome Research Institute (NHGRI)CompletedAlzheimer DiseaseUnited States
-
Wayne State UniversityThe New School for Social ResearchCompletedChronic Pain (Back / Neck)United States
-
Abramson Cancer Center at Penn MedicineFox Chase Cancer CenterCompletedCardiovascular Diseases | Cancer | Hereditary Cancer | Hereditary Cardiac AmyloidosisUnited States
-
University of MiamiNational Institute on Minority Health and Health Disparities (NIMHD)CompletedPost Traumatic Stress DisorderUnited States
-
Duke UniversityCompletedCancer of the GI System-stages II III and IVUnited States
-
Boston UniversityNational Institute of Mental Health (NIMH)CompletedPost-Traumatic Stress DisorderUnited States